Relative to pharmacy benefits managers, managed care laws, notice of drug pricing optionsand pharmacy benefit manager business practices.
The bill amends existing laws related to the operations of pharmacy benefits managers, raising administrative fines for violations and enforcing stricter reporting requirements. Additionally, pharmacies are required to notify consumers about their rights to request the lowest available prices for their medications, thereby empowering them with information that can lead to cost savings. This aspect of the bill intends to create a more consumer-friendly environment within the healthcare system.
SB665 aims to enhance consumer protection in the pharmaceutical industry by implementing regulations on pharmacy benefits managers (PBMs) and improving transparency in drug pricing. The bill mandates that PBMs form written agreements with health carriers to ensure accountability. This suggests a move toward more structured relationships between these parties, with an emphasis on lawful conduct in managing prescription drug benefits.
While the supportive arguments highlight the importance of consumer rights and transparency, opponents may argue that these regulations could lead to increased operational burdens on both pharmacies and PBMs. As more stringent laws are placed on these entities, there is a concern that it could affect pricing structures and potentially limit the flexibility of PBMs in negotiating drug prices with manufacturers.
In enforcing these new standards, the bill allows for increased scrutiny of PBMs and requires them to provide clearer information regarding drug pricing and rebates. This could significantly affect how consumers engage with pharmacies and how these entities navigate the complex landscape of drug pricing and coverage. If passed, this legislation is set to take effect from January 1, 2027, marking a significant shift in how pharmacy benefits are managed in New Hampshire.